ConductScience.org, home

Paper7657280

A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis.

Combes B and 9 others. Hepatology, 1995. Cited by 265 papers, by iCite.

Cite this record

ConductScience Library. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Papers, record 7657280. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7657280

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis.
PubMed
Journal
Hepatology
PubMed
Year
1995
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
265
iCite
Relative citation ratio, by iCite
8.29
iCite
Revised in PubMed
2013-11-21
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Combes BB
2Carithers RL JrR L
3Maddrey WCW C
4Lin DD
5McDonald MFM F
6Wheeler DED E
7Eigenbrodt EHE H
8Muñoz SJS J
9Rubin RR
10Garcia-Tsao GG

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Liver Cirrhosis, BiliaryMajor topic
Ursodeoxycholic AcidMajor topic
Adult
Bile
Bilirubin
Double-Blind Method
Female
Humans
Liver
Male
Middle Aged
Placebos
Time Factors
Treatment Failure

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
M01-RR00065NCRR NIH HHSUnited StatesM01RR000065PubMed and NIHNIH RePORTER
M01-RR00125NCRR NIH HHSUnited StatesM01RR000125PubMed and NIHNIH RePORTER
M01-RR00633NCRR NIH HHSUnited StatesM01RR000633PubMed and NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00006168Ursodiol-Methotrexate for Primary Biliary CirrhosisBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by65

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 265 citations.

PMIDTitleJournalYearIn PapersSource
41898408Potential Therapeutic Strategies for Steatosis, Oxidative Stress, Inflammation, and Fibrosis in Liver Disease.Int J Mol Sci2026https://conductscience.org/library/papers/41898408PubMed
41440960The Personalized Management of Primary Biliary Cholangitis in the Era of Precision Medicine: Current Challenges and Future Perspectives.J Pers Med2025https://conductscience.org/library/papers/41440960PubMed
40977287Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis.Aliment Pharmacol Ther2026https://conductscience.org/library/papers/40977287PubMed
40568038Primary biliary cholangitis: A historical perspective from xanthomatous lesions to modern molecular biology.World J Gastrointest Pathophysiol2025https://conductscience.org/library/papers/40568038PubMed
40115760Bile acid therapy for primary biliary cholangitis: Pathogenetic validation.World J Exp Med2025https://conductscience.org/library/papers/40115760PubMed
38178006Pharmacotherapy for primary biliary cholangitis: an assessment of medication candidacy and rates of treatment.BMC Gastroenterol2024https://conductscience.org/library/papers/38178006PubMed
37408803Emerging Therapeutic Strategies in The Fight Against Primary Biliary Cholangitis.J Clin Transl Hepatol2023https://conductscience.org/library/papers/37408803PubMed
36910199Biological synthesis of ursodeoxycholic acid.Front Microbiol2023https://conductscience.org/library/papers/36910199PubMed
33486884Rodent models of cholestatic liver disease: A practical guide for translational research.Liver Int2021https://conductscience.org/library/papers/33486884PubMed
32039371New treatments/targets for primary biliary cholangitis.JHEP Rep2019https://conductscience.org/library/papers/32039371PubMed
31970467Emerging therapies for PBC.J Gastroenterol2020https://conductscience.org/library/papers/31970467PubMed
30859149A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis.Hepatol Commun2019https://conductscience.org/library/papers/30859149PubMed
30632051Treatment of Fatigue in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.Dig Dis Sci2019https://conductscience.org/library/papers/30632051PubMed
29928160Update on New Drugs and Those in Development for the Treatment of Primary Biliary Cholangitis.Gastroenterol Hepatol (N Y)2018https://conductscience.org/library/papers/29928160PubMed
29593060The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.Gut2018https://conductscience.org/library/papers/29593060PubMed
29520309Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review.Beilstein J Org Chem2018https://conductscience.org/library/papers/29520309PubMed
29404429Update on pharmacotherapies for cholestatic liver disease.Hepatol Commun2017https://conductscience.org/library/papers/29404429PubMed
29051789Novel strategies and therapeutic options for the management of primary biliary cholangitis.Ther Adv Gastroenterol2017https://conductscience.org/library/papers/29051789PubMed
28350426Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/28350426PubMed
27700211Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update.J Manag Care Spec Pharm2016https://conductscience.org/library/papers/27700211PubMed

See all 65 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7657280

GET https://conductscience.org/api/papers/v1/7657280/cited_by?page=2